| 51 |
25963122 | Mycophenolate mofetil may induce prolonged severe anemia during pegylated-interferon/ribavirin/simeprevir therapy in liver transplant recipients. | 2015 Jun |
1 |
| 52 |
26078754 | IFN-λ: A New Class of Interferon with Distinct Functions-Implications for Hepatitis C Virus Research. | 2015 |
2 |
| 53 |
26118427 | Alisporivir plus ribavirin, interferon free or in combination with pegylated interferon, for hepatitis C virus genotype 2 or 3 infection. | 2015 Oct |
1 |
| 54 |
26177560 | Interleukin- 28B: a prognostic marker in interferon based therapy of chronic HCV patients of the Pakistan with variable treatment response. | 2015 Sep |
1 |
| 55 |
26684004 | Kinetic response of wild and mutant core codon 70 strains of HCV genotype 1b to pegylated interferon-α and ribavirin therapy. | 2015 Dec 18 |
2 |
| 56 |
27442378 | New Therapies for Hepatitis C Virus. | 2015 |
2 |
| 57 |
24022240 | Individualized therapy for hepatitis C infection: focus on the interleukin-28B polymorphism in directing therapy. | 2014 Feb |
2 |
| 58 |
24145541 | Ribavirin inhibits in vitro hepatitis E virus replication through depletion of cellular GTP pools and is moderately synergistic with alpha interferon. | 2014 |
1 |
| 59 |
24171456 | Impaired HCV clearance in HIV/HCV coinfected subjects treated with PegIFN and RBV due to interference of IFN signaling by IFNαR2a. | 2014 Jan |
2 |
| 60 |
24329856 | Impact of ribavirin priming on viral kinetics and treatment response in chronic hepatitis C genotype 1 infection. | 2014 Jan |
3 |
| 61 |
24367041 | IFNL4-ΔG genotype is associated with slower viral clearance in hepatitis C, genotype-1 patients treated with sofosbuvir and ribavirin. | 2014 Jun 1 |
3 |
| 62 |
24488144 | Drug resistance of a viral population and its individual intrahost variants during the first 48 hours of therapy. | 2014 Jun |
1 |
| 63 |
24584067 | Amino acid sequence analysis in patients with chronic HCV genotype 1b infection during pegylated interferon-α2a and ribavirin therapy. | 2014 |
1 |
| 64 |
24621321 | Severe thrombocytopenia in a patient with inosine triphosphatase (ITPA)-CC genotype caused by pegylated interferon (IFN)-α-2a with ribavirin therapy: a case report. | 2014 Mar 12 |
1 |
| 65 |
24657484 | Efficacy of immunotherapy with TG4040, peg-interferon, and ribavirin in a Phase 2 study of patients with chronic HCV infection. | 2014 Jul |
1 |
| 66 |
24670522 | The cost-effectiveness of improved hepatitis C virus therapies in HIV/hepatitis C virus coinfected patients. | 2014 Jan 28 |
1 |
| 67 |
24677184 | Cost analysis of sofosbuvir/ribavirin versus sofosbuvir/simeprevir for genotype 1 hepatitis C virus in interferon-ineligible/intolerant individuals. | 2014 Jul |
2 |
| 68 |
24700342 | Ribavirin improves the IFN-γ response of natural killer cells to IFN-based therapy of hepatitis C virus infection. | 2014 Oct |
7 |
| 69 |
24793175 | Efficacy of re-treatment by peginterferon alpha-2a and ribavirin in a child with hepatitis C. | 2014 Jul |
1 |
| 70 |
24845459 | Temporal evolution of human autoantibody response to cytoplasmic rods and rings structure during anti-HCV therapy with ribavirin and interferon-α. | 2014 Oct |
1 |
| 71 |
24848437 | Investigational nucleoside and nucleotide polymerase inhibitors and their use in treating hepatitis C virus. | 2014 Sep |
1 |
| 72 |
24957263 | Ribavirin uptake into human hepatocyte HHL5 cells is enhanced by interferon-α via up-regulation of the human concentrative nucleoside transporter (hCNT2). | 2014 Sep 2 |
1 |
| 73 |
24994464 | Low IL10 serum levels as key factor for predicting the sustained virological response to IFNα/ribavirin in Brazilian patients with HCV carrying IL28B CT/TT genotype. | 2014 Aug |
1 |
| 74 |
25077851 | Role of baseline depressive symptoms in the development of depressive episode in patients receiving antiviral therapy for hepatitis C infection. | 2014 Aug |
3 |
| 75 |
25097047 | Serum complements C3 and C4 in chronic HCV infection and their correlation with response to pegylated interferon and ribavirin treatment. | 2014 Jun |
2 |
| 76 |
25132867 | Successful natural interferon-β plus ribavirin therapy in a chronic hepatitis C patient after discontinuation of interferon-α treatment due to arrhythmia and interstitial pneumonia. | 2014 Aug |
1 |
| 77 |
25171028 | Meta-analysis: influence of host and viral factors in patients with chronic hepatitis C genotype 4 treated with pegylated interferon and ribavirin. | 2014 Nov |
1 |
| 78 |
25326107 | Persistent neurocognitive decline in a clinic sample of hepatitis C virus-infected persons receiving interferon and ribavirin treatment. | 2014 Dec |
1 |
| 79 |
25355997 | In-vitro antiviral efficacy of ribavirin and interferon-alpha against canine distemper virus. | 2014 Oct |
1 |
| 80 |
25364884 | Re-treatment of chronic hepatitis C virus genotype 1 infection after relapse: an open-label pilot study. | 2014 Nov 4 |
2 |
| 81 |
25369007 | Association of SNPs in interferon receptor genes in chronic hepatitis C with response to combined therapy of interferon and ribavirin. | 2014 |
1 |
| 82 |
25473172 | Ribavirin induced hemolysis: a novel mechanism of action against chronic hepatitis C virus infection. | 2014 Nov 21 |
2 |
| 83 |
25548485 | Study of pruritus in chronic hepatitis C patients. | 2014 Dec 21 |
1 |
| 84 |
25548683 | IFNL4 ss469415590 Variant Is Associated with Treatment Response in Japanese HCV Genotype 1 Infected Individuals Treated with IFN-Including Regimens. | 2014 |
1 |
| 85 |
25664085 | Soluble TRAIL levels decreased in chronic hepatitis C treatment with pegylated interferon α plus ribavirin: association with viral responses. | 2014 |
1 |
| 86 |
25705565 | Host Genetic Factors and Dendritic Cell Responses Associated with the Outcome of Interferon/Ribavirin Treatment in HIV-1/HCV Co-Infected Individuals. | 2014 Oct 31 |
1 |
| 87 |
23216931 | Serum peptides, represented by complement 3f des-arginine, are useful for prediction of the response to pegylated interferon-α plus ribavirin in patients with chronic hepatitis C. | 2013 Jul |
1 |
| 88 |
23280583 | Hepatitis C virus load and expression of a unique subset of cellular genes in circulating lymphoid cells differentiate non-responders from responders to pegylated interferon alpha-ribavirin treatment. | 2013 Mar |
1 |
| 89 |
23359491 | JUMP-C: a randomized trial of mericitabine plus pegylated interferon alpha-2a/ribavirin for 24 weeks in treatment-naïve HCV genotype 1/4 patients. | 2013 Aug |
2 |
| 90 |
23403428 | Persistence of resistant variants in hepatitis C virus-infected patients treated with the NS5A replication complex inhibitor daclatasvir. | 2013 May |
1 |
| 91 |
23449803 | MicroRNA-27a regulates lipid metabolism and inhibits hepatitis C virus replication in human hepatoma cells. | 2013 May |
2 |
| 92 |
23553458 | Analysis of sequences of hepatitis C virus NS5A genotype 1 in HIV-coinfected patients with a null response to nitazoxanide or peg-interferon plus ribavirin. | 2013 Sep |
1 |
| 93 |
23559897 | Ribavirin Does Not Impair the Suppressive Activity of Foxp3(+)CD4(+)CD25(+) Regulatory T Cells. | 2013 Feb |
1 |
| 94 |
23637397 | Response of hepatitis C virus to long-term passage in the presence of alpha interferon: multiple mutations and a common phenotype. | 2013 Jul |
1 |
| 95 |
23942001 | Efficacy of pegylated interferon α-2b and ribavirin in chronic hepatitis C virus (genotypes 1 and 4) infection. | 2013 Dec |
1 |
| 96 |
24204676 | Can antidepressants prevent pegylated interferon-α/ribavirin-associated depression in patients with chronic hepatitis C: meta-analysis of randomized, double-blind, placebo-controlled trials? | 2013 |
1 |
| 97 |
24254131 | Treatment of genotype 2 and genotype 3 hepatitis C virus (HCV) infection in human immunodeficiency virus positive patients. | 2013 Dec |
1 |
| 98 |
24281016 | Prediction of response to pegylated interferon/ribavirin combination therapy for chronic hepatitis C genotypes 2a and 2b and high viral load. | 2013 |
1 |
| 99 |
24490062 | Involvement of Differential Relationship between HCV Replication and Hepatic PRR Signaling Gene Expression in Responsiveness to IFN-Based Therapy. | 2013 |
1 |
| 100 |
24579307 | [The function and application of the IL28B gene in HCV infection and treatment]. | 2013 Nov |
2 |